Sleep apnea-hypopnea syndrome and type 2 diabetes. A reciprocal relationship?;Síndrome de apneas-hipopneas del sueño y diabetes tipo 2. ¿Una relación de ida y vuelta?

Archivos de Bronconeumologia

Volumn 51, Issue 3, 2015, Pages 128-139

  Martínez Cerón, Elisabet ^a   Casitas Mateos, Raquel ^a   García Río, Francisco ^a,b,c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Diabetes; Glucose; Hypoxia; Insulin; Sleep apnea

Indexed keywords

HORMONE; GLUCOSE;

ADRENERGIC SYSTEM; ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; KIDNEY DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RETINOPATHY; RISK ASSESSMENT; SHORT SURVEY; SLEEP DISORDERED BREATHING; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; PREVALENCE; PROGNOSIS; SLEEP APNEA, OBSTRUCTIVE; DIABETIC NEPHROPATHY; FOOD INTAKE; INSULIN RESISTANCE; MICROVASCULARIZATION; RISK FACTOR; SLEEP TIME;

DIABETES MELLITUS, TYPE 2; HUMANS; PREVALENCE; PROGNOSIS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84923278488     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2014.12.007     Document Type: Short Survey

References (164)

1. Lloberes P., Durán-Cantolla J., Martínez-García M.A., Marín J.M., Ferrer A., Corral J., et al. Diagnóstico y tratamiento del síndrome de apneas-hipopneas durante el sueño. Arch Bronconeumol 2011, 47:143-156.
2. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep disorders breathing among middle aged adults. N Engl J Med 1993, 328:1230-1236.
3. Durán J., Esnaola S., Ramón R., Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 years. Am J Respir Crit Care Med 2001, 163:685-689.
4. Marin J.M., Carrizo S.J., Vicente E., Agustí A.G.N. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet 2005, 365:1046-1053.
5. Campos-Rodriguez F., Peña-Griñan N., Reyes-Nuñez N., de la Cruz-Moron I., Perez-Ronchel J., de la Vega-Gallardo F., et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005, 128:624-633.
6. Martínez-García M.A., Campos-Rodríguez F., Catalán-Serra P., Soler-Cataluña J.J., Almeida-Gonzalez C., de la Cruz Morón I., et al. Cardiovascular mortality in obstructive sleep apnea in the elderly: Role of long-term continuous positive airway pressure treatment: A prospective observational study. Am J Respir Crit Care Med 2012, 186:909-916.
7. Terán-Santos J., Jiménez-Gómez A., Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1999, 340:847-851.
8. Barbé, Pericás J., Muñoz A., Findley L., Antó J.M., Agustí A.G. Automobile accidents in patients with sleep apnea syndrome. Am J Respir Crit Care Med 1998, 158:18-22.
9. Barbé F., Durán-Cantolla J., Sánchez-de-la-Torre M., Martínez-Alonso M., Carmona C., Barceló A., et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: A randomized controlled trial. JAMA 2012, 307:2161-2168.
10. García-Río F., Racionero M.A., Pino J.M., Martínez I., Ortuño F., Villasante C., et al. Sleep apnea and hypertension. Chest 2000, 117:1417-1425.
11. Montserrat J.M., Garcia-Rio F., Barbe F. Diagnostic and therapeutic approach to nonsleepy apnea. Am J Respir Crit Care Med 2007, 176:6-9.
12. Durán-Cantolla J., Aizpuru F., Montserrat J.M., Ballester E., Terán-Santos J., Aguirregomoscorta J.I., et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: Randomised controlled trial. BMJ 2010, 341:1-9.
13. Barbé F., Durán-Cantolla J., Capote F., de la Peña M., Chiner E., Masa J.F., et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010, 181:718-726.
14. Marin J.M., Agusti A., Villar I., Forner M., Nieto D., Carrizo S.J., et al. Association between treated and undtreated obstructive sleep apnea and risk of hypertension. JAMA 2012, 307:2169-2176.
15. Martínez-García M.A., Capote F., Campos-Rodríguez F., Lloberes P., Díaz de Atauri M.J., Somoza M., et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: The HIPARCO randomized clinical trial. JAMA 2013, 310:2407-2415.
16. Alonso-Fernández A., García-Río F., Racionero M.A., Pino J.M., Ortuño F., Martínez I., et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest 2005, 127:15-22.
17. Arias M.A., García-Rio F., Alonso-Fernández A., Mediano O., Martínez I., Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function. Effects of nasal continuous positive airway pressure in men. Circulation 2005, 112:375-383.
18. Alonso-Fernández A., García-Río F., Arias M.A., Mediano O., Pino J.M., Martínez I., et al. Obstructive sleep apnoea-hypoapnoea syndrome reversibly depresses cardiac response to exercise. Eur Heart J 2006, 27:207-215.
19. Garcia-Rio F., Alonso-Fernández A., Armada E., Mediano O., Lores V., Rojo B., et al. CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol 2013, 168:1328-1335.
20. Arias M.A., García-Rio F., Alonso-Fernández A., Martínez I., Villamor J. Pulmonary hypertension in obstructive sleep apnoea: Effects of continuous airway pressure: A randomized, controlled crossover study. Eur Heart J 2006, 27:1106-1113.
21. Alonso-Fernández A., de la Peña M., Romero D., Piérola J., Carrera M., Barceló A., et al. Association between obstructive sleep apnea and pulmonary embolism. May Clin Proc 2013, 88:579-587.
22. Parra O., Arboix A., Bechich S., García-Eroles L., Montserrat J.M., López J.A., et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000, 161:375-380.
23. Martínez-García M.A., Soler-Cataluña J.J., Ejarque-Martínez L., Soriano Y., Román-Sánchez P., Barbé Illa F., et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: A 5-year follow-up study. Am J Respir Crit Care Med 2009, 180:36-41.
24. Parra O., Sánchez-Armengol A., Bonnin M., Arboix A., Campos-Rodríguez F., Pérez-Ronchel J., et al. Early treatment of obstructive apnoea and stroke outcome: A randomised controlled trial. Eur Respir J 2011, 37:1128-1136.
25. Martínez-García M.A., Campos-Rodríguez F., Soler-Cataluña J.J., Catalán-Serra P., Román-Sánchez P., Montserrat J.M. Increased incidence of non-fatal cardiovascular events in stroke patients with sleep apnoea. Effect of CPAP treatment. Eur Respir J 2012, 39:906-912.
26. Campos-Rodriguez F., Martinez-Garcia M.A., Martinez M., Duran-Cantolla J., Peña M., Masdeu M.J., et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med 2013, 187:99-105.
27. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28:S37-S42. American Diabetes Association.
28. Guariguata L., Whiting D.R., Hambleton I., Beagle J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diab Res Clin Pract 2014, 103:137-149.
29. International Diabetes Federation. IDF diabetes atlas [revista electrónica] 2010 [consultado 3 May 2014]: Disponible en: http://www. idf.org/diabetesatlas.
30. Kahn C.R., Saltiel A.R. The molecular mechanism of insulin action and the regulation of glucose and lipid metabolism. Joslin's diabetes mellitus 2005, 4:145-168. Lippincott Williams & Wilkins, Boston.
31. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev 2005, 26:19-39.
32. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
33. Stoohs R.A., Facchini F., Guilleminault C. Insulin resistance and sleepdisordered breathing in healthy humans. Am J Respir Crit Care Med 1996, 154:170-174.
34. Ip M.S.M., Lam B., Ng M.M.T., Lam W.K., Tsang K.W.T., Lam K.S.L. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670-676.
35. Makino S., Handa H., Suzukawa K., Fujiwara M., Nakamura M., Muraoka S., et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxford) 2006, 64:12-19.
36. Theorell-Haglöw J., Berne C., Janson C., Lindberg E. Obstructive sleep apnoea is associated with decreased insulin sensitivity in females. Eur Respir J 2008, 31:1054-1060.
37. Lindberg E., Theorell-Haglow J., Svensson M., Gislason T., Berne C., Janson C. Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest 2012, 142:935-942.
38. Pamidi S., Wroblewski K., Broussard J., Day A., Hanlon E.C., Abraham V., et al. Obstructive sleep apnea in young lean men: Impact on insulin sensitivity and secretion. Diabetes Care 2012, 35:2384-2389.
39. Lin Q.C., Zhang X.B., Chen G.P., Huang D.Y., Din H.B., Tang A.Z. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath 2012, 16:571-578.
40. Punjabi N.M., Sorkin J.D., Katzel L.I., Goldberg A.P., Schwartz A.R., Smith P.L. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165:677-682.
41. Sulit L., Storfer-Isser A., Kirchner H.L., Redline S. Differences in polysomnography predictors for hypertension and impaired glucose tolerance. Sleep 2006, 29:777-783.
42. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R., Resnick H.E. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol 2004, 160:521-530.
43. Cizza G., Piaggi P., Lucassen E.A., de Jonge L., Walter M., Mattingly M.S., et al. Obstructive sleep apnea is a predictor of abnormal glucose metabolism in chronically sleep deprived obese adults. PLoS One 2013, 8:e65400.
44. Shin C., Kim J., Kim J., Lee S., Shim J., In K., et al. Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am J Respir Crit Care Med 2005, 171:287-291.
45. Joo S., Lee S., Choi H.A., Kim J., Kim E., Kimm K., et al. Habitual snoring is associated with elevated hemoglobin A1c levels in non-obese middle-aged adults. J Sleep Res 2006, 15:437-444.
46. Spiegel K., Leproult R., van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 23:1435-1439.
47. Ayas N.T., White D.P., Al-Delaimy W.K., Manson J.E., Stampfer M.J., Speizer F.E., et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003, 26:380-384.
48. Reichmuth K.J., Austin D., Skatrud J.B., Young T. Association of sleep apnea and type II diabetes: A population-based study. Am J Respir Crit Care Med 2005, 172:1590-1595.
49. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreier F., Pickering T.G., et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 2007, 30:1667-1673.
50. Lam J.C.M., Tan K.C.B., Lai A.Y.K., Lam D.C.L., Ip M.S.M. Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea. Sleep Med 2012, 13:15-20.
51. Priou P., le Vaillant M., Meslier N., Chollet S., Masson P., Humeau M.P., et al. Independent association between obstructive sleep apnea severity and glycated hemoglobin in adults without diabetes. Diabetes Care 2012, 35:1902-1906.
52. Gottlieb D.J., Yenokyan G., Newman A.B., O'Connor G.T., Punjabi N.M., Quan S.F., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The sleep heart health study. Circulation 2010, 122:352-360.
53. Shim U., Lee H., Oh J.-Y., Sung Y.-A. Sleep disorder and cardiovascular risk factors among patients with type 2 diabetes mellitus. Korean J Intern Med 2011, 26:277-284.
54. West S.D., Nicoll D.J., Stradling J.R. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006, 61:945-950.
55. Laaban J.-P., Daenen S., Léger D., Pascal S., Bayon V., Slama G., et al. Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab 2009, 35:372-377.
56. Foster G.D., Borradaile K.E., Sanders M.H., Millman R., Zammit G., Newman A.B., et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: The Sleep AHEAD study. Arch Intern Med 2009, 169:1619-1626.
57. Hall M.H., Okun M.L., Sowers M., Matthews K.A., Kravitz H.M., Hardin K., et al. Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: The SWAN Sleep Study. Sleep 2012, 35:783-790.
58. Newman A.B., Nieto F.J., Guidry U., Lind B.K., Redline S., Pickering T.G., et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: The Sleep Heart Health Study. Am J Epidemiol 2001, 154:50-59.
59. Resnick H.E., Redline S., Shahar E., Gilpin A., Newman A., Walter R., et al. Diabetes and sleep disturbances: Findings from the Sleep Heart Health Study. Diabetes Care 2003, 26:702-709.
60. Gottlieb D.J., Punjabi N.M., Newman A.B., Resnick H.E., Redline S., Baldwin C.M., et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005, 165:863-867.
61. Marshall N.S., Wong K.K.H., Phillips C.L., Liu P.Y., Knuiman M.W., Grunstein R.R. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?. J Clin Sleep Med 2009, 5:15-20.
62. Celen Y.T., Hedner J., Carlson J., Peker Y. Impact of gender on incident diabetes mellitus in obstructive sleep apnea: A 16-year follow-up. J Clin Sleep Med 2010, 6:244-250.
63. Mahmood K., Akhter N., Eldeirawi K., Onal E., Christman J.W., Carley D.W., et al. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J Clin Sleep Med 2009, 5:215-221.
64. Redline S., Sotres-Alvarez D., Loredo J., Hall M., Patel S.R., Ramos A., et al. Sleep-disordered breathing in Hispanic/Latino individuals of diverse backgrounds. The Hispanic Community Health Study/Study of Latinos. Am J Respir Crit Care Med 2014, 189:335-344.
65. Botros N., Concato J., Mohsenin V., Selim B., Doctor K., Yaggi H.K. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009, 122:1122-1127.
66. Wang X., Bi Y., Zhang Q., Pan F. Obstructive sleep apnoea and the risk of type 2 diabetes: A meta-analysis of prospective cohort studies. Respirology 2013, 18:140-146.
67. Cheng N., Cai W., Jiang M., Wu S. Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res 1997, 41:852-856.
68. Raff H., Bruder E.D., Jankowski B.M., Colman R.J. Effect of neonatal hypoxia on leptin, insulin, growth hormone and body composition in the rat. Horm Metab Res 2001, 33:151-155.
69. Braun B., Rock P.B., Zamudio S., Wolfel G.E., Mazzeo R.S., Muza S.R., et al. Women at altitude: Short-term exposure to hypoxia and/or 1-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 2001, 91:623-631.
70. Oltmanns K.M., Gehring H., Rudolf S., Schultes B., Rook S., Schweiger U., et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004, 169:1231-1237.
71. Iiyori N., Alonso L.C., Li J., Sanders M.H., Garcia-Ocana A., O'Doherty R.M., et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007, 175:851-857.
72. Yokoe T., Alonso L.C., Romano L.C., Rosa T.C., O'Doherty R.M., Garcia-Ocana A., et al. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 2008, 586:899-911.
73. Louis M., Punjabi N. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J App Physiol 2009, 106:1538-1544.
74. Tamura A., Kawano Y., Watanabe T., Kadota J. Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status. Sleep Med 2012, 13:1050-1055.
75. Grimaldi D., Beccuti G., Touma C., van Cauter E., Mokhlesi B. Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: Therapeutic implications. Diabetes Care 2014, 37:355-363.
76. Cantley J., Grey S.T., Maxwell P.H., Withers D.J. The hypoxia response pathway and β-cell function. Diabetes Obes Metab 2010, 12:159-167.
77. 2 consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PloS One 2012, 7:e29807.
78. VanHelder T., Symons J.D., Radomski M.W. Effects of sleep deprivation and exercise on glucose tolerance. Aviat Space Environ Med 1993, 64:487-492.
79. Spiegel K., Leproult R., L'Hermite-Baleriaux M., Copinschi G., Penev P.D., Van Cauter E. Leptin levels are dependent on sleep duration: Relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004, 89:5762-5771.
80. Shimizu K., Chin K., Nakamura T., Masuzaki H., Ogawa Y., Hosokawa R., et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 2002, 57:429-434.
81. Yaggi H.K., Araujo A.B., McKinlay J.B. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006, 29:657-661.
82. Mallon L., Browman J.E., Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration; a 12-year follow-up study of a middle-aged population. Diabetes Care 2005, 28:2762-2767.
83. Bjorkelund C., Bondyr-Carlsson D., Lapidus L., Lissner L., Månsson J., Skoog I., et al. Sleep disturbances in midlife unrelated to 32-year diabetes incidence: Ghe prospective population study of women in Gothenburg. Diabetes Care 2005, 28:2739-2744.
84. Ip M., Mokhlesi B. Sleep and glucose intolerance/diabetes mellitus. Sleep Med Clin 2007, 2:19-29.
85. Knutson K.L., Ryden A.M., Mander B.A., Van Cauter E. Role of sleep duration and quality in the risk and severity of type II diabetes mellitus. Arch Intern Med 2006, 166:1768-1774.
86. Nilsson P.M., Roost M., Engstrom G., Hedblad B., Berglund G. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 2004, 27:2464-2469.
87. Meisinger C., Heier M., Loewel H. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005, 48:235-241. MONICA/KORA Augsburg Cohort Study.
88. Barcelo A., Barbe F., de la Pena M., Martinez P., Soriano J.B., Piérola J., et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008, 63:946-950.
89. Van Cauter E., Polonsky K.S., Scheen A.J. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997, 18:716-738.
90. Kern W., Offenheuser S., Born J., Fehm H.L. Entrainment of ultradian oscillations in the secretion of insulin and glucagon to the nonrapid eye movement/rapid eye movement sleep rhythm in humans. J Clin Endocrinol Metab 1996, 81:1541-1547.
91. Surani S., Aguillar R., Komari V., Surani A., Subramanian S. Influence of Hispanic ethnicity in prevalence of diabetes mellitus on sleep apnea and relationship to sleep phase. Postgrad Med 2009, 121:108-112.
92. Bopparaju S., Surani S. Sleep and diabetes. Int J Endocrinol 2010, 2010:759509.
93. Aurora R.N., Punjabi N.M. Obstructive sleep apnoea and type 2 diabetes mellitus: A bidirectional association. Lancet Respir Med 2013, 1:329-338.
94. Aurora R.N., Punjabi N.M. Sleep apnea and metabolic dysfunction: Cause or co-relation?. Sleep Med Clin 2007, 2:237-250.
95. Deibert D.C., DeFronzo R.A. Epinephrine-induced insulin resistance in man. J Clin Invest 1980, 65:717-721.
96. Avogaro A., Toff olo G., Valerio A., Cobelli C. Epinephrine exerts opposite eff ects on peripheral glucose disposal and glucosestimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study. Diabetes 1996, 45:1373-1378.
97. Lechin F., van der Dijs B. Central nervous system circuitry involved in the hyperinsulinism syndrome. Neuroendocrinology 2006, 84:222-234.
98. Lembo G., Capaldo B., Rendina V., Iaccarino G., Napoli R., Guida R., et al. Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol Endocrinol Metab 1994, 266:E242-E247.
99. Punjabi N.M., Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005, 99:1998-2007.
100. García-Río F., Pino J.M., Ramirez T., Alvaro D., Alonso A., Villasante C., et al. Inspiratory neural drive response to hypoxia adequately estimates peripheral chemosensitivity in OSAHS patients. Eur Respir J 2002, 20:724-732.
101. McNicholas W.T., Bonsignore M.R. Sleep apnoea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms and research priorities. Eur Respir J 2007, 29:156-178. Management Committee of EU COST ACTION B26.
102. Harsch I.A., Schahin S.P., Radespiel-Tröger M., Weintz O., Jahreiss H., Fuchs F.S., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004, 169:156-162.
103. Lavie L. Oxidative stress, inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci 2012, 4:1391-1403.
104. Bloch-Damti A., Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal 2005, 7:1553-1567.
105. Robertson R.P. Oxidative stress and impaired insulin secretion in type 2 diabetes. Curr Opin Pharmacol 2006, 6:615-619.
106. Xu J., Long Y.-S., Gozal D., Epstein P.N. Beta-cell death and proliferation after intermittent hypoxia: Role of oxidative stress. Free Radic Biol Med 2009, 46:783-790.
107. Xu W., Chi L., Row B.W., Xu R., Ke Y., Xu B., et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 2004, 126:313-323.
108. Li J., Thorne L., Punjabi N., Sun C., Schwartz A., Smith P., et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 2005, 97:698-706.
109. Polotsky V.Y., Li J., Punjabi N.M., Rubin A.E., Smith P.L., Schwartz A.R., et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003, 552:253-264.
110. Pialoux V., Hanly P.J., Foster G.E., Brugniaux J.V., Beaudin A.E., Hartmann S.E., et al. Effects of exposure to intermittent hypoxia on oxidative stress and acute hypoxic ventilatory response in humans. Am J Respir Crit Care Med 2009, 180:1002-1009.
111. Barceló A., Barbé F., de la Peña M., Vila M., Pérez G., Piérola J., et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 2006, 27:1-5.
112. Alonso-Fernández A., García-Río F., Arias M.A., Hernanz A., de la Peña M., Piérola J., et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: A randomised trial. Thorax 2009, 64:581-586.
113. Golbidi S., Badran M., Laher I. Antioxidant and anti-inflammatory effects of exercise in diabetic patients. Exp Diabetes Res 2012, 2012:941864.
114. Barone M.T.U., Menna-Barreto L. Diabetes and sleep: A complex cause-and-effect relationship. Diabetes Res Clin Pract 2011, 91:129-137.
115. Duncan B.B., Schmidt M.I., Pankow J.S., Ballantyne C.M., Couper D., Vigo A., et al. Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes 2003, 52:1799-1805.
116. Moller D.E. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000, 11:212-217.
117. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
118. Arias M.A., García-Río F., Alonso-Fernández A., Hernanz A., Hidalgo R., Martínez-Mateo V., et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008, 32:1009-1015.
119. Donath M., Schumann D., Faulenbach M., Ellingsgaard H., Perren A., Ehses J. Islet inflammation in type 2 diabetes. Diabetes Care 2008, 31:161-164.
120. Richardson S., Willcox A., Bone A., Foulis A., Morgan N. Islet-associated macrophages in type 2 diabetes. Diabetología 2009, 52:1686-1688.
121. Bahceci M., Gokalp D., Bahceci S., Tuzcu A., Atmaca S., Arikan S. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?. J Endocrinol Invest 2007, 30:210-214.
122. Monzillo L.U., Hamdy O., Horton E.S., Ledbury S., Mullooly C., Jarema C., et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obesity Res 2003, 11:1048-1054.
123. De Oliveira Leal V., Mafra D. Adipokines in obesity. Clin Chim Acta 2013, 419:87-94.
124. Mantzoros C.S., Magkos F., Brinkoetter M., Sienkiewicz E., Dardeno T.A., Kim S.Y., et al. Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 2011, 301:E567-E584.
125. Marroqui L., Gonzalez A., Ñeco P., Caballero-Garrido E., Vieira E., Ripoll C., et al. Role of leptin in the pancreatic beta-cell: Eff ects and signaling pathways. J Mol Endocrinol 2012, 49:R9-R17.
126. Shehzad A., Iqbal W., Shehzad O., Lee Y.S. Adiponectin: Regulation of its production and its role in human diseases. Hormones 2012, 11:8-20.
127. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008, 29:2959-2971.
128. Rajala M.W., Obici S., Scherer P.E., Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003, 111:225-230.
129. Spiegel K., Tasali E., Penev P., Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850.
130. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E., Watson W., Kerr K., Jones R., et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003, 88:5452-5455.
131. McTernan P.G., Fisher F.M., Valsamakis G., Chetty R., Harte A., McTernan C.L., et al. Resistin and type 2 diabetes: Regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003, 88:6098-6106.
132. Szapary P.O., Bloedon L.T., Samaha F.F., Duffy D., Wolfe M.L., Soffer D., et al. Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome. Arterioscler Thromb Vasc Biol 2006, 26:182-188.
133. Yamamoto Y., Fujiuchi S., Hiramatsu M., Nishigaki Y., Takeda A., Fujita Y., et al. Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 2008, 76:377-385.
134. Cherneva R.V., Georgiev O.B., Petrova D.S., Mondeshki T.L., Ruseva S.R., Cakova A.D., et al. Resistin - the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea. J Diabetes Metab Disord 2013, 12:5.
135. Coste O., Beers P.V., Bogdan A., Charbuy H., Touitou Y. Hypoxic alterations of cortisol circadian rhythm in man after simulation of a long duration flight. Steroids 2005, 70:803-810.
136. Entzian P., Linnemann K., Schlaak M., Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996, 153:1080-1086.
137. Bratel T., Wennlund A., Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 1999, 93:1-7.
138. Rees P.J., Prior J.G., Cochrane G.M., Clark T.J. Sleep apnoea in diabetic patients with autonomic neuropathy. J R Soc Med 1981, 74:192-195.
139. West S.D., Groves D.C., Lipinski H.J., Nicoll D.J., Mason R.H., Scanlon P.H., et al. The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea. Diabet Med 2010, 27:423-430.
140. Buyukaydin B., Akkoyunlu M.E., Kazancioglu R., Karakose F., Ozcelik H.K., Erkoc R., et al. The effect of sleep apnea syndrome on the development of diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 2012, 98:140-143.
141. Aronsohn R.S., Whitmore H., van Cauter E., Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010, 181:507-513.
142. Rice T.B., Foster G.D., Sanders M.H., Unruh M., Reboussin D., Kuna S.T., et al. The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus. Sleep 2012, 35:1293-1298.
143. Seicean S., Strohl K.P., Seicean A., Gibby C., Marwick T.H. Sleep disordered breathing as a risk of cardiac events in subjects with diabetes mellitus and normal exercise echocardiographic findings. Am J Cardiol 2013, 111:1214-1220.
144. Pallayova M., Banerjee D., Taheri S. Novel insights into metabolic sequelae of obstructive sleep apnoea: A link between hypoxic stress and chronic diabetes complications. Diabetes Res Clin Pract 2014, 104:197-205.
145. Tahrani A.A., Ali A., Raymond N.T., Begum S., Dubb K., Mughal S., et al. Obstructive sleep apnea and diabetic neuropathy: A novel association in patients with type 2 diabetes. Am J Respir Crit Care Med 2012, 186:434-441.
146. Tan K.C.B., Chow W.S., Lam J.C.M., Lam B., Bucala R., Betteridge J., et al. Advanced glycation endproducts in non-diabetic patients with obstructive sleep apnea. Sleep 2006, 29:329-333.
147. Jelic S., Lederer D.J., Adams T., Padeletti M., Colombo P.C., Factor P.H., et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010, 121:1014-1021.
148. Banerjee D., Leong W.B., Arora T., Nolen M., Punamiya V., Grunstein R., et al. The potential association between obstructive sleep apnea and diabetic retinopathy in severe obesity-the role of hypoxemia. PLoS One 2013, 8:e79521.
149. Shiba T., Maeno T., Saishin Y., Hori Y., Takahashi M. Nocturnal intermittent serious hypoxia and reoxygenation in proliferative diabetic retinopathy cases. Am J Ophthalmol 2010, 149:959-963.
150. Altaf Q., Dodson P., Ali A. Obstructive sleep apnoea is associated with sight threatening retinopathy and predicts the development of preproliferative and proliferative retinopathy in patients with type 2 diabetes: A longitudinal analysis. Diabet Med 2013, 30:E5.
151. Rudrappa S., Warren G., Idris I. Obstructive sleep apnoea is associated with the development and progression of diabetic retinopathy, independent of conventional risk factors and novel biomarkers for diabetic retinopathy. Br J Ophtalmol 2012, 96:1535.
152. Schober A.-K., Neurath M.F., Harsch I.A. Prevalence of sleep apnoea in diabetic patients. Clin Respir J 2011, 5:165-172.
153. Al-Jahdali H. Prevalence of sleep apnea and excessive day time sleepiness in patients with end-stage renal disease on dialysis. Saudi J Kidney Dis Transpl 2012, 23:251-261.
154. Mayer P., Dematteis M., Pépin J.L., Wuyam B., Veale D., Vila A., et al. Peripheral neuropathy in sleep apnea. Am J Respir Crit Care Med 1999, 159:213-219.
155. Raman R., Gupta A., Venkatesh K., Kulothungan V., Sharma T. Abnormal sleep patterns in subjects with type II diabetes mellitus and its effect on diabetic microangiopathies: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 20). Acta Diabetol 2012, 49:255-261.
156. Kashine S., Kishida K., Funahashi T., Yasuda T., Okita K., Matsuzawa Y., et al. Selective contribution of waist circumference reduction on the improvement of sleep-disordered breathing in patients hospitalized with type 2 diabetes mellitus. Intern Med 2011, 50:1895-1903.
157. Fujihara K., Kodama S., Horikawa C., Yoshizawa S., Sugawara A., Hirasawa R., et al. The relationship between diabetic neuropathy and sleep apnea syndrome: A meta-analysis. Sleep Disord 2013, 2013:150371.
158. Hein M.S., Schlenker E.H., Patel K.P. Altered control of ventilation in streptozotocin-induced diabetic rats. Proc Soc Exp Biol Med 1994, 207:213-219.
159. Bottini P., Redolfi S., Dottorini M.L., Tantucci C. Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. Respiration 2008, 75:265-271.
160. Tantucci C., Scionti L., Bottini P., Dottorini M.L., Puxeddu E., Casucci G., et al. Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest 1997, 112:145-153.
161. Casellini C.M., Vinik A.I. Clinical manifestations and current treatment options for diabetic neuropathies. Endocr Pract 2007, 13:550-566.
162. Kuna S.T., Reboussin D.M., Borradaile K.E., Sanders M.H., Millman R.P., Zammit G., et al. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes. Sleep 2013, 36. 641-9A.
163. Peppard P.E., Young T., Palta M., Dempsey J., Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000, 284:3015-3021.
164. Newman A.B., Foster G., Givelber R., Nieto F.J., Redline S., Young T. Progression and regression of sleep-disordered breathing with changes in weight: The Sleep Heart Health Study. Arch Intern Med 2005, 165:2408-2413.